KSS Earnings

KSS reported its earnings on 2026-05-28, showcasing a revenue of 3.00B against an estimate of 3.03B, resulting in a -0.99% surprise. The EPS was -0.13, surpassing the expected -0.18 by 27.78%. The stock experienced a 20.57% price change on the earnings day and a 22.58% change over the next five days, reflecting market reactions to the results.

Following KSS's earnings announcement on 2026-05-28, the stock price moved by 20.57% on the day of the release. Over the subsequent five days, it saw a 22.58% change. Historically, KSS's stock price tends to shift by an average of 5.06% in the 10 days leading up to earnings and 1.6% in the 10 days following, providing insight into potential market.

For 2027/Q2, analysts estimate KSS's annual revenue to reach 3.38B, while the EPS is projected at 0.49. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between KSS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, KSS's stock price typically moves by 5.06% in the 10 days before its earnings and 1.6% in the 10 days after. For the upcoming 2027/Q2 earnings, analysts expect an EPS of 0.49 and revenue of 3.38B.

The earnings call summary indicates a decline in revenue, gross margin, net income, and EPS, reflecting weak financial performance. Despite strategic initiatives and forward-looking statements, the lack of detailed discussion on operational updates and shareholder returns, along with the acknowledgment of risks and uncertainties, suggests a cautious outlook. With a market cap of $2.58 billion, the stock is likely to experience a negative reaction, potentially falling between -2% to -8% over the next two weeks.